Tam CS - Search Results

1

Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL.

Blombery P, Lew TE, Dengler MA, Thompson ER, Lin VS, Chen X, Nguyen T, Panigrahi A, Handunnetti SM, Carney DA, Westerman DA, Tam CS, Adams JM, Wei AH, Huang DCS, Seymour JF, Roberts AW, Anderson MA. Blombery P, et al. Among authors: tam cs. Blood. 2022 Feb 24;139(8):1198-1207. doi: 10.1182/blood.2021012775. Blood. 2022. PMID: 34469514 Free PMC article. Clinical Trial.

2

Diffuse large B-cell non-Hodgkin's lymphoma presenting as Sister Joseph's nodule.

Tam C, Turner H, Hicks RJ, Seymour JF. Tam C, et al. Leuk Lymphoma. 2002 Oct;43(10):2055-7. doi: 10.1080/1042819021000016005. Leuk Lymphoma. 2002. PMID: 12481909 Review.

3

Fludarabine and cyclophosphamide using an attenuated dose schedule is a highly effective regimen for patients with indolent lymphoid malignancies.

Tam CS, Wolf MM, Januszewicz EH, Prince HM, Westerman D, Seymour JF. Tam CS, et al. Cancer. 2004 May 15;100(10):2181-9. doi: 10.1002/cncr.20234. Cancer. 2004. PMID: 15139062 Free article. Review.

4

Leukaemic subtype of marginal zone lymphoma: a presentation of three cases and literature review.

Tam CS, Prince HM, Westerman D, Seymour JF, Juneja S. Tam CS, et al. Leuk Lymphoma. 2004 Apr;45(4):705-10. doi: 10.1080/10428190310001615657. Leuk Lymphoma. 2004. PMID: 15160943 Review.

5

Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignancies.

Tam CS, Galanos J, Seymour JF, Pitman AG, Stark RJ, Prince HM. Tam CS, et al. Am J Hematol. 2004 Sep;77(1):72-6. doi: 10.1002/ajh.20147. Am J Hematol. 2004. PMID: 15307110 Free article.

6

A new model for predicting infectious complications during fludarabine-based combination chemotherapy among patients with indolent lymphoid malignancies.

Tam CS, Wolf MM, Januszewicz EH, Grigg AP, Prince HM, Westerman D, Seymour JF. Tam CS, et al. Cancer. 2004 Nov 1;101(9):2042-9. doi: 10.1002/cncr.20615. Cancer. 2004. PMID: 15372472 Free article.

7

Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies.

Tam C, Seymour JF, Brown M, Campbell P, Scarlett J, Underhill C, Ritchie D, Bond R, Grigg AP. Tam C, et al. Haematologica. 2005 May;90(5):700-2. Haematologica. 2005. PMID: 15921393

8

Ante-mortem diagnosis of localized invasive esophageal aspergillosis in a patient with acute myeloid leukemia.

Chionh F, Herbert KE, Seymour JF, Prince HM, Wolf M, Zimet A, Tam C, Kennedy GA. Chionh F, et al. Leuk Lymphoma. 2005 Apr;46(4):603-5. doi: 10.1080/10428190400025138. Leuk Lymphoma. 2005. PMID: 16019490

9

Fludarabine combination therapy is highly effective in first-line and salvage treatment of patients with Waldenström's macroglobulinemia.

Tam CS, Wolf MM, Westerman D, Januszewicz EH, Prince HM, Seymour JF. Tam CS, et al. Clin Lymphoma Myeloma. 2005 Sep;6(2):136-9. doi: 10.3816/CLM.2005.n.040. Clin Lymphoma Myeloma. 2005. PMID: 16231852

10

The infectious consequences of rituximab addition to fludarabine-containing regimens.

Tam CS, Seymour JF. Tam CS, et al. Blood. 2006 Apr 1;107(7):3013-4. doi: 10.1182/blood-2005-10-4012. Blood. 2006. PMID: 16554491 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

330 results

Search Page